Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.12.001 ◽

2021 ◽

Author(s):

Dimitrios Patoulias ◽

Theodoros Michailidis ◽

Christodoulos Papadopoulos ◽

Asterios Karagiannis ◽

Michael Doumas

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Effect of glucagon-like peptide-1 on major cardiovascular outcomes in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.07.199 ◽

2016 ◽

Vol 222 ◽

pp. 957-962 ◽

Cited By ~ 11

Author(s):

Song Ding ◽

Yong-ping Du ◽

Nan Lin ◽

Yuan-yuan Su ◽

Fan Yang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2020.03.021 ◽

2020 ◽

Vol 30 (8) ◽

pp. 1260-1271 ◽

Cited By ~ 2

Author(s):

Omid Asbaghi ◽

Mehdi Sadeghian ◽

Faezeh Fouladvand ◽

Bahman Panahande ◽

Morteza Nasiri ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Lipid Profile ◽

Zinc Supplementation ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery diseases: a systematic review and meta-analysis of randomized controlled trials

Pharmacological Research ◽

10.1016/j.phrs.2021.105765 ◽

2021 ◽

pp. 105765

Author(s):

Lidan Wang ◽

Qiqi Xin ◽

Ya Wang ◽

Zhuhong Chen ◽

Rong Yuan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Coronary Artery Diseases ◽

Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2016.05.022 ◽

2017 ◽

Vol 31 (7) ◽

pp. 1237-1242 ◽

Cited By ~ 30

Author(s):

Mohsen Mazidi ◽

Ehsan Karimi ◽

Peyman Rezaie ◽

Gordon A. Ferns

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Serum Crp

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Asian Journal of Andrology ◽

10.4103/1008-682x.122346 ◽

2014 ◽

Vol 16 (1) ◽

pp. 146 ◽

Cited By ~ 62

Author(s):

Kun-Jie Wang ◽

Hong Li ◽

Xiang Cai ◽

Chen-Xi Cao ◽

Ye Tian ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Metabolic Effects ◽

Controlled Trials ◽

Testosterone Replacement Therapy ◽

Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Diabetes Therapy ◽

10.1007/s13300-020-00882-2 ◽

2020 ◽

Vol 11 (9) ◽

pp. 2121-2143

Author(s):

Liyun He ◽

Na Yang ◽

Lingling Xu ◽

Fan Ping ◽

Wei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Effect of SGLT2 inhibitor on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

International Urology and Nephrology ◽

10.1007/s11255-019-02112-6 ◽

2019 ◽

Vol 51 (4) ◽

pp. 655-669 ◽

Cited By ~ 4

Author(s):

Chaojie Feng ◽

Minxiang Wu ◽

Zhengyue Chen ◽

Xiongwei Yu ◽

Zhenyu Nie ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Renal Function ◽

Meta Analysis ◽

Sglt2 Inhibitor ◽

Controlled Trials ◽

Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Obesity Reviews ◽

10.1111/obr.12318 ◽

2015 ◽

Vol 16 (12) ◽

pp. 1071-1080 ◽

Cited By ~ 29

Author(s):

N. M. Aldekhail ◽

J. Logue ◽

P. McLoone ◽

D. S. Morrison

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Glycaemic Control ◽

Meta Analysis ◽

Controlled Trials ◽

Obese Patients ◽